Intra venous therapy complications

  • 7,137 views
Uploaded on

 

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
No Downloads

Views

Total Views
7,137
On Slideshare
0
From Embeds
0
Number of Embeds
1

Actions

Shares
Downloads
227
Comments
1
Likes
2

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide
  • Reinforce correct vein name on nursing documentation while pointing out each vein.
  • Note redness between the ink lines - phlebitis
  • Photo of phlebitis from a midline catheter. Most likely chemical phlebitis
  • Phenergan is a very dangerous medication to be administered peripherally. If it comes in contact with an artery it will cause arterial necrosis also. Medication package insert advises that IM route is best, and gives serious caution to IV administration. Most patients can tolerate this medication rectally. Currently there is a high incidence of litigation related to peripheral IV administration of phenergan and resultant damage to vessels and tissue. Dilantin has a very high pH, should be given in a central line through a dedicated port. Administration of ANY other medication or fluid through that port increases the risk of precipitation and line occlusion.
  • Peripheral extravasation injury. Note that the site is near point of flexion, which causes increased risk of occurrence
  • Extravasation injury on child
  • Port extravasation can be caused by Huber needle not being properly placed in port or coming out of port, disconnection of catheter from port reservoir, damage to catheter. Presence of rapid and adequate blood return is essential prior to administration of vesicant. Site should be observed frequently during administration.
  • Two weeks later
  • Granulating extravasation wound
  • Granulating wound from extravasation
  • Healed wound from extravasation.

Transcript

  • 1. Complications ofIntravenous Therapy Principles of IV Therapy ADN136 Fall Qr 09
  • 2. Complications of IV Therapy Nursing assumed the role of intravenous therapy in the 1940’s Application of the nursing process is critical in the prevention of complications 90% of hospitalized patients receive IV fluids and medications
  • 3. Complications of IV Therapy Classified according to their location  Local complication: at or near the insertions site or as a result of mechanical failure  Systemic complications: occur within the vascular system, remote from the IV site. Can be serious and life threatening
  • 4. Local complications Occur as adverse reactions or trauma to the surrounding venipuncture site Assessing and monitoring are the key components to early intervention Good venipuncture technique is the main factor related to the prevention of most local complications associated with IV Therapy. Local complications include: hematoma, thrombosis, phlebitis, postinfusion phlebitis, thrombophlebitis, infiltration, extravasation, local infection, and veno spasm.
  • 5. Hematoma Hematoma and ecchymosis demote formations resulting from the infiltration of blood into the tissues at the venipuncture site  Related to venipuncture technique  Use of large bore cannula: Trauma to the vein during insertion  Patients receiving anticoagulant therapy and long term steroids
  • 6. Hematoma Subcutaneous hematoma is the most common complication Can be a starting point for other complications: thrombophlebitis and infection Related to:  Nicking the vein  Discontinuing the IV without apply adequate pressure  Applying the tourniquet to tightly above a priviously attempted venipuncture site.
  • 7. Hematoma Signs and symptoms:  Discoloration of the skin  Site swelling and discomfort  Inability to advance the cannula all the way into the vein during insertion  Resistance to positive pressure during the lock flushing procedure
  • 8. Hematoma Prevention Use of an indirect method Apply tourniquet just before venipuncture Use a small need in the elderly and patients on steriods, or patients with thin skin. Use blood pressure cuff to apply pressure Be gentle
  • 9. Hematoma Treatment Apply direct, light pressure for 2-3 minutes after needle removed Have patient elevate extremity Apply Ice Document
  • 10. Thrombosis Catheter-related obsturctions can be mechanical or non-thrombotic Trauma to the endothelial cells of the venous wall causes red blood cells to adhere to the vein wall, forms a clot or Thrombosis Drip rate slows, line does not flush easily, resistance is felt Never forcible flush a catheter
  • 11. Thrombosis Types of Thrombus or occlusion Persistent withdrawal occlusion Partial occlusion Complete occlusion Fibrin tail Fibrin sheath Mural thrombosis
  • 12. “In Need of tPA Occlusions” Intaluminal thrombus Fibrin Flap “Reopen the Pipeline”, Hadaway C, Nursing. 2005, 35(8)Total OcclusionProbable cause: Intraluminal thrombus Symptom:Unable to infuse or aspiratePartial OcclusionProbable cause: Fibrin flapSymptom: Unable to aspirate “Reopen the Pipeline”, Hadaway C, Nursing. 2005, 35(8)
  • 13. Thrombosis Types of Thrombus or occlusion Thrombosis related to:  Hypertensive pt; blood backing up  Low flow rate  Location of the IV cannula  Compression of the IV line for an extended period of time  Trauma to the wall of the vein
  • 14. Thrombosis Signs and Symptoms  Fever and Malaise  Slowed or stopped infusion rate  Inability to flush Prevention  Use pumps and controllers to manage flow rate  Microdrip tubing for rate below50mL/hr  Avoid areas of flexion  Use filters  Avoid lower extremeties
  • 15. Thrombosis Treatment  Never flush a cannula to remove an occlusion  Discontunue the cannula  Notify the physician and assess the site for circulatory impairment Document
  • 16. Phlebitis Inflammation of the vein in which the endothelial cells of the venous wall become irritated and cells roughen, allowing platelets to adhere and predispose the vein to inflamation-induced phlebitis  Tender to touch and can be very painful
  • 17. Phlebitis Mechanical:  To large a catheter for the size of the vein  Manipulation of the catheter: improper stabilization Chemical: vein becomes inflamed by irritating or vessicant solutions or medication  Irritation medication or solution  Improperly mixed or diluted  Too-rapid infusion  Presence of particulate matter
  • 18. Phlebitis Chemical (cont):  The more acidic the IV solution the greater the risk  Additives: Potassium  Type of material  Length of dwell:  30% by day 2, 39-40% by day 3 (Macki and Ringer)  The slower the rate of infusion the less irritation
  • 19. Chemical Phlebitis - Nafcillin
  • 20. Phlebitis Bacterial Also called Septic phlebitis: least common Inflammation of the intima of the vein Contributing factors  Poor aseptic technique  Failure to detect breaks in the integrity of the equipment  Poor insertion technique  Inadequate stabilization  Failure to perform site assessment  Aseptic preparation of solutions  Hand washing and preparing the skin
  • 21. Phlebitis Postinfusion Inflamation of the vein 48-96 hr after discontinued Factors that contribute:  Insertion technique  Condition of the vein used  Type, compatibility, pH of solution used  Gauge, size, length, and material  Dwell time  Infrequent dressing change  Host factors: age, gender, age and presence of disease
  • 22. Phlebitis Immune system causes leukocytes to gather at the inflamed site Pyrogens stimulate the hypothalamus to raise body temperature Pyrogens stimulate bone marrow to release more leukocytes Redness and tenderness increase
  • 23. Phlebitis Signs and Symptoms  Redness at the site  Site warm to touch  Local swelling  Palpable cord along the vein  Sluggish infusion rate  Increase in basal temperature of 1degree C or more Prevention  Use larger veins for hypertonic solutions  Central lines for Infusions lasting longer than 5 days
  • 24. Phlebitis Scale 0 – No clinical symptoms 1- Erythema at access site with or without pain 2- Pain at access site, with erythema and / or edema 3- Pain at access site with erythema and / or edema, streak formation, and palpable venous cord 4- Pain at access site with erythema and / or edema, streak formation, palpable venous cord > 1 inch, purulent drainage
  • 25. Thrombophlebitis Thrombophlebitis denotes a twofold injury: thrombosis and inflammation Related to:  Use of veins in the lower extremity  Use of hypertonic or highly acidic infusion solutions  Causes similar to those leading to phlebitis
  • 26. Thrombophlebitis Signs and Symptoms  Sluggish flow rate  Edema in the limbs  Tender and cord like vein  Site warm to the touch  Visible red line above venipuncture site  Diminished arterial pulses  Mottling and cyanosis of the extremities
  • 27. Thrombophlebitis Prevention  Use veins in the forearm rather than the hands  Do not use veins in a joint  Assess site q 4 hr in adults, q 2 hr in children  Catheter securment  Infuse at rate prescribed  Use the smallest size catheter to do the job  Proper dilution
  • 28. Thrombophlebitis Septic thrombophlebits can be prevented:  Appropriate skin preparation  Aseptic technique in the maintance of infusion  Proper hand hygiene  60% from patients skin  35% from the line itself  5% from hands
  • 29. Infiltration The inadvertent administration of a non- vesicant solution into surrounding tissue Dislodgment of the catheter from the vein Second to phlebitis as a cuase of IV therapy morbidity
  • 30. Infiltration Related to:  Puncture of the distal vein wall during access  Puncture of the vein wall by mechanical friction  Dislodgement of the catheter from the intima of the vien  Poor securment  High delivery rate  Overmanipulation
  • 31. Infiltration Signs and Symptoms  Coolness of the skin around site  Taut skin  Dependent edema  Absence of blood return  “Pinkish” blood return  Infusion rate slows
  • 32. Infiltration Complications fall into 3 catagories  Ulceration and possible tissue necrosis  Compartment syndrome  Reflex sympathetic dystrophy syndrome
  • 33. Infiltration – What else is wrong withthis picture?
  • 34. Cellulitis from PIV
  • 35. Extravasation Inadvertent administration of a vesicant solution into surrounding tissue  Vesicant is a fluid or medication that causes the formation of blisters, with subsequent sloughing of tissues occurring from the tissue necrosis Extravasations related to:  Puncture of the distal wall  Mechanical friction  Dislodgement of the catheter
  • 36. Examples of Vesicants  Phenergan pH is 4 to 5.5  Dilantin pH is 12 (Drano has a pH of 14)  High concentration KCL pH is 5 to 7.8  Calcium gluconate pH is 6.2  Amphotericin B pH is 5.7 to 8  Dopamine pH is 2.5 to 5  Nipride pH is 3.5 to 6  10%, 20% or 50% dextrose pH is 3.5 to 6.5  Sodium bicarbonate pH is 7 to 8.5
  • 37. Extravasations Signs and Symptoms  Complaints of pain or burning  Swelling proximal to or distal to the IV site  Puffiness of the dependent part of the limb  Skin tightness at the veinpuncture site  Blanching and coolness of the skin  Slow or stopped infusion  Damp or wet dressing
  • 38. Extravasations Prevention:  Use of skilled practitioners  Knowledge of vesicants  Condition of the patients veins  Drug administration technique  If continuous give in CVAD  Only with brisk blood return of 3-5 cc  Use of a free flow IV  Do not use a pump on vesicants given peripherally  Assess for blood return frequently
  • 39. Extravasations (cont) Prevention (cont)  Site of venous access  Condition of the patient  Vomiting, coughing, retchin  Sedated  Unable to communicate  Treatment
  • 40. Extravasation
  • 41. Phenergan – Intra-arterial
  • 42. Phenergan Intra-arterial
  • 43. Dilantin Extravasation
  • 44. Other Complications Local infection:  Microbial contamination of the cannula or the infusate  Thrombus becomes infected Venous Spasm: a sudden involuntary contraction of a vein or an artery resulting in temporary cessation of blood flow through a vessel
  • 45. Systemic Complications We will cover when we talk about Central Venous Access Devices